{"title":"Product Focus","authors":"","doi":"10.1177/10870571080130091501","DOIUrl":null,"url":null,"abstract":"Cellectricon has introduced the Cellaxess®HT System, an automated system for reagent-free transfection that enables reagent-free delivery of siRNA and cDNA to host cells at a throughput of 50,000 wells per day. The system uses capillary electrode arrays for reagent-free transfection of cells directly in 384-well plates. The plates are designed for high-content screening (HCS) readout and are compatible with","PeriodicalId":15087,"journal":{"name":"Journal of Biomolecular Screening","volume":"13 1","pages":"922 - 927"},"PeriodicalIF":0.0000,"publicationDate":"2008-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/10870571080130091501","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomolecular Screening","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10870571080130091501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 0
Abstract
Cellectricon has introduced the Cellaxess®HT System, an automated system for reagent-free transfection that enables reagent-free delivery of siRNA and cDNA to host cells at a throughput of 50,000 wells per day. The system uses capillary electrode arrays for reagent-free transfection of cells directly in 384-well plates. The plates are designed for high-content screening (HCS) readout and are compatible with
期刊介绍：
Advancing the Science of Drug Discovery: SLAS Discovery reports how scientists develop and utilize novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease.
SLAS Discovery is a peer-reviewed journal that publishes scientific reports that enable and improve target validation, evaluate current drug discovery technologies, provide novel research tools, and incorporate research approaches that enhance depth of knowledge and drug discovery success.
SLAS Discovery emphasizes scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/optimization; chemical biology; and informatics (data analysis, image analysis, statistics, bio- and chemo-informatics). Review articles on target biology, new paradigms in drug discovery and advances in drug discovery technologies.
SLAS Discovery is of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
